| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject (NCT05398510) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2022-06-30 |
| Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA Nephropathy (NCT05528991) | Shenzhen Second People's Hospital | 2022-06-01 |
| Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN) (NCT05125068) | Eledon Pharmaceuticals | 2022-03-21 |
| Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease (NCT05083364) | Arrowhead Pharmaceuticals | 2022-02-01 |
| A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy (NCT05182775) | Shanxi Provincial People's Hospital | 2022-01-01 |
| A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy (NCT04905212) | RemeGen Co., Ltd. | 2021-11-04 |
| A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. (NCT05016323) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-09 |
| Steroids Therapy in IgA Nephropathy With Crescents (NCT04833374) | Sixth Affiliated Hospital, Sun Yat-sen University | 2021-05-24 |
| SodiUm Restriction by Behavioral Intervention (NCT04805047) | First Affiliated Hospital Xi'an Jiaotong University | 2021-05-15 |
| Atrasentan in Patients With Proteinuric Glomerular Diseases (NCT04573920) | Novartis Pharmaceuticals | 2021-03-15 |
| Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients (NCT04578834) | Novartis Pharmaceuticals | 2021-01-25 |
| Atrasentan in Patients With IgA Nephropathy (NCT04573478) | Novartis Pharmaceuticals | 2020-12-11 |
| The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy (NCT04438603) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2020-10-01 |
| Rituximab and RASi in Patients with IgAN (NCT04525729) | Nan Chen,MD | 2020-07-01 |
| A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy (NCT05824390) | XIEJINGYUAN | 2020-06-20 |
| Correlation of Microbiome and Metabonomics With IgA Nephropathy (NCT05190848) | Guangdong Provincial People's Hospital | 2020-05-01 |
| Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy (NCT04042623) | Aravive, Inc. | 2019-11-27 |
| KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis (NCT03929887) | Seoul National University Hospital | 2019-05-01 |
| Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN) (NCT03945318) | Novartis Pharmaceuticals | 2019-04-08 |
| First in Human Study to Assess Safety of VIS649 in Healthy Subjects (NCT03719443) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2018-10-09 |
| Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy (NCT03608033) | Omeros Corporation | 2018-04-05 |
| Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies (NCT03453619) | Apellis Pharmaceuticals, Inc. | 2018-02-26 |
| Treatment of IgA Nephropathy According to Renal Lesions (NCT03188887) | Assistance Publique - Hôpitaux de Paris | 2018-02-20 |
| Longterm Renal Oucomes of STOP-IgAN Trial Participants (NCT03488368) | RWTH Aachen University | 2018-02-01 |
| A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX (NCT03366337) | Biogen | 2017-12-26 |
| Fecal Microbiota Transplantation for Refractory IgA Nephropathy (NCT03633864) | Air Force Military Medical University, China | 2017-11-22 |
| Efficacy and Safety of Atacicept in IgA Nephropathy (NCT02808429) | EMD Serono Research & Development Institute, Inc. | 2017-01-31 |
| Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy (NCT03218852) | Guangdong Provincial People's Hospital | 2016-12-01 |
| Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy (NCT02981212) | Yonsei University | 2016-06-01 |
| Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy (NCT02662283) | Sun Yat-sen University | 2016-05-01 |
| Registry of IgA Nephropathy in Chinese Children (NCT03015974) | Peking University First Hospital | 2016-01-01 |
| Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy (NCT02433236) | Rigel Pharmaceuticals | 2015-09-01 |
| Acthar on Proteinuria in IgA Nephropathy Patients (NCT02382523) | Baylor College of Medicine | 2015-02-01 |
| BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy (NCT02052219) | Anthera Pharmaceuticals | 2014-10-01 |
| Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy (NCT02112838) | Rigel Pharmaceuticals | 2014-10-01 |
| Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy (NCT02231125) | Chen Xiangmei | 2014-09-01 |
| Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f. (NCT02187900) | Second Xiangya Hospital of Central South University | 2014-06-01 |
| The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients (NCT01854814) | Fan Fan Hou | 2013-07-01 |
| BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration (NCT02062684) | Anthera Pharmaceuticals | 2013-06-01 |
| The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients (NCT02493101) | Chulalongkorn University | 2013-04-01 |
| IgA Nephropathy, Lymphocyte Homing and IgA Class Switch (NCT01775527) | University Hospital, Limoges | 2013-02-01 |
| Probiotics in IgA Nephropathy (NCT01781312) | Uppsala University Hospital | 2013-01-01 |
| Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy (NCT01758120) | Guangdong Provincial People's Hospital | 2012-12-01 |
| IgA Nephropathy Registration Initiative of High Quality (INSIGHT) (NCT03001947) | Sun Yat-sen University | 2012-11-01 |
| Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy (NCT02526966) | Centre Hospitalier Universitaire de Saint Etienne | 2012-03-01 |
| Biomarkers for the Progression of IgA Nephropathy (NCT02529722) | Istanbul University | 2012-01-01 |
| An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data (NCT01502579) | Guangdong Provincial People's Hospital | 2011-09-01 |
| Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers (NCT01237028) | Yonsei University | 2011-03-01 |
| Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy (NCT02471599) | Sun Yat-sen University | 2011-03-01 |
| The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy (NCT01451710) | Nanjing University School of Medicine | 2011-03-01 |
| A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients (NCT01224028) | Astellas Pharma Inc | 2010-11-01 |
| Diet Intervention in Food Sensitive Patients With IgA Nephropathy (NCT01203007) | Uppsala University Hospital | 2010-09-01 |
| Pilot Study of Velcade® in IgA Nephropathy (NCT01103778) | The Rogosin Institute | 2010-07-01 |
| Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath (NCT01879514) | Shanghai University of Traditional Chinese Medicine | 2010-01-01 |
| National Registry of Rare Kidney Diseases (NCT06065852) | UK Kidney Association | 2009-11-06 |
| Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease (NCT01129557) | Columbia University | 2009-09-01 |
| Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade (NCT00922311) | The University of Hong Kong | 2009-07-01 |
| Aliskiren for Immunoglobulin A (IgA) Nephropathy (NCT00870493) | Chinese University of Hong Kong | 2009-04-01 |
| Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy (NCT00856674) | Osprey Pharmaceuticals USA, Inc. | 2009-03-01 |
| Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis (NCT00885547) | Nanjing University School of Medicine | 2009-03-01 |
| Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy (NCT00498368) | Mayo Clinic | 2009-02-01 |
| Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy (NCT00554502) | RWTH Aachen University | 2008-02-01 |
| Paricalcitol for the Treatment of Immunoglobulin A Nephropathy (NCT00599963) | Chinese University of Hong Kong | 2008-01-01 |
| Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy (NCT00549692) | Kuhnil Pharmaceutical Co., Ltd. | 2007-11-01 |
| Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) (NCT00657059) | Sun Yat-sen University | 2007-09-01 |
| A Controlled Study of Uric Acid on the Progression of IgA Nephropathy (NCT00793585) | Sun Yat-sen University | 2007-07-01 |
| A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy (NCT00426348) | Guangdong Provincial People's Hospital | 2007-05-01 |
| Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy (NCT00319761) | Chinese University of Hong Kong | 2006-05-01 |
| Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy (NCT00396721) | Josep m Cruzado | 2006-01-01 |
| Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study (NCT00767221) | Calliditas Therapeutics AB | 2005-10-01 |
| Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy (NCT00301600) | Nanjing University School of Medicine | 2003-01-01 |
| Mycophenolate Mofetil for IgA Nephropathy (NCT00863252) | The University of Hong Kong | 2002-03-01 |
| Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (NCT00318474) | St. Joseph's Hospital and Medical Center, Phoenix | 2002-01-01 |
| Steroids and Azathioprine in Advanced IgAN (NCT01392833) | A. Manzoni Hospital | 1999-12-01 |
| "Steroids and Azathioprine Versus Steroids Alone in IgAN" (NCT00755859) | A. Manzoni Hospital | 1998-05-01 |
| Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy (NCT00367562) | Hospital Britanico | 1996-01-01 |
| Managed Access Programs for EXV811, Atrasentan (NCT07319585) | Novartis Pharmaceuticals | |